In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy

Infezioni in Medicina

Volumn 13, Issue 2, 2005, Pages 97-102

  Pistella, Eleonora ^a   Falcone, Marco ^a   Baiocchi, Pia ^a   Pompeo, Maria Elena ^a   Perciaccante, Antonio ^a   Penni, Adrio ^a   Venditti, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Device associated infections; Fosfomycin; Glycopeptide failure; Staphylococcus aureus

Indexed keywords

FOSFOMYCIN; GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; DEVICE INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROSTHESIS INFECTION; PROTEIN SYNTHESIS INHIBITION; REDUCTION; STAPHYLOCOCCUS AUREUS; STRAIN IDENTIFICATION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD VESSEL PROSTHESIS; CATHETERIZATION; DEVICE REMOVAL; DRAINAGE; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ELECTROPHORESIS, GEL, PULSED-FIELD; EQUIPMENT CONTAMINATION; FOSFOMYCIN; GLYCOPEPTIDES; HUMANS; MEDIASTINITIS; METHICILLIN RESISTANCE; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 22544458774     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vaudax P., Lew D.P., Waldvogel F.A. Host factors predisposing to and influencing therapy of foreign body infections. In: Infections associated with in-dwelling medical devices (Bisno A.L., Waldvogel F.A., Eds.) 1994, pp 1-29. 2nd Ed. American Society for Microbiology, Washington DC.
2. Chuard C., Lucet J.C., Rohner P. et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J. Infect. Dis. 163, 1369-1373, 1991.
3. Pavoni G.L., Giannella M., Falcone M. et al. Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clin. Microbiol. Infect. 10, 831-837, 2004.
4. Fluckiger U., Zimmerli W. Factors influencing antimicrobial therapy of surface-adhering microrganism. In: Pandalai SG (ed.), Recent Res Devel Antimicrob Agents Chemother 2000; 4: 165-75.
5. Stewart P.S., Costeron J.W. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-138, 2001.
6. Venditti M., Baiocchi P., Brandimarte C. et al. High rate of oxacillin-resistant Staphylococcus aureus isolates in a tertiary-care university hospital. J. Chemother. 6, 25-28, 1994.
7. Baiocchi P., Capone A., Carfagna P. et al. Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among Staphylococcus aureus isolates in a tertiary-care university hospital. Int. J. Antimicrob. Agents 7, 93-96, 1996.
8. Hiramatsu K., Hanaki H., Ino T. et al. Methicillin-resistant Staphylococcus aureus clinical strains with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-136, 1997.
9. Venditti M., Baiocchi P., Santini C. et al. Potential of clindamycin in addition to vancomycin for the treatment of oxacillin-resistant Staphylococcus aureus septicaemia persisting under vancomycin therapy. Int. J. Antimicrob. Agents 5, 123-128, 1995.
10. Levine D.P., Fromm B.S., Reddy B.R. Slow response to vancomycin or vancomycin plus rifampicin therapy among patients with methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115, 674-680, 1991.
11. Sieradzki K., Roberts R.B., Haber S.W. et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340, 517-523, 1999.
12. Fosgen A., Walzer M. Antimicrobial activity of fosfomycin in vitro. J. Antimicrob. Chemother. 11, 467-471, 1983.
13. Grif K., Dierich M.P., Pfaller K. et al. In vitro activity of fosfomycin in combination with various antistaphyloccal substances. J. Antimicrob. Chemother. 48, 209-217, 2001.
14. Tarasi A., Cassone M., Monaco M. et al. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. J. Chemother. 15, 281-285, 2003.
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; fourth edition. Approved standard, document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa 1999.
16. rd ed. The Williams and Wilkins Co., Baltimore, 1991
17. Mato R., Santos Sanchez I., Venditti M. et al. Spread of multi-drug resistant Iberian clone of methicillin-resistant Staphylococcus aureus (MRSA) to Italy and Scotland. Microb. Drug Resist. 4, 107-112, 1998.
18. Andrews J.M., Baquero F., Beltran J. et al. International collaborative study on standardization of bacterial sensitivity to fosfomycin. J. Antimicrob. Chemother. 12, 357-361, 1983.
19. Small P.M., Chambers H.F. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34, 1227-1231, 1990.
20. Staphylococcus aureus with reduced susceptibility to vancomycin - United States 1997. MMWR Morb. Mortal. Wkly. Rep. 46, 813-815, 1997.
21. Burnie J., Matthew R., Jiman-Fatami A. et al. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin. Clin. Infect. Dis. 31, 684-690, 2000.
22. Grif K., Dierich M.P., Pfaller K. et al. In vitro activity of fosfomycin in combination with various antistaphylococcal substances. J. Antimicrob. Chemother. 48, 209-217, 2001.
23. Amorena B., Gracia E., Monzon M. et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J. Antimicrob. Chemother. 44, 43-55, 1999.
24. Cassone M., Campanile F., Pantosti A. et al. Identification of a variant "Rome Clone" of methicillin resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an Intensive Care Unit. Microb. Drug Resist. 10, 43-49, 2004.
25. Pavoni G.L., Falcone M., Baiocchi P. et al. Conservative medical therapy of infections following osteosynthesis: a retrospective analysis of a six-year experience. J. Chemother. 14, 378-383, 2002.